First gene therapy approach for MLC leukoencephalopathy designated as orphan drug
The European Medicines Agency (EMA) has designated as an orphan drug the first gene therapy approach to treat megalencephalic leukoencephalopathy with
Source: ub.edu
Stay updated with breaking news from Subcortical Cysts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The European Medicines Agency (EMA) has designated as an orphan drug the first gene therapy approach to treat megalencephalic leukoencephalopathy with